NO964348L - CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner - Google Patents

CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner

Info

Publication number
NO964348L
NO964348L NO964348A NO964348A NO964348L NO 964348 L NO964348 L NO 964348L NO 964348 A NO964348 A NO 964348A NO 964348 A NO964348 A NO 964348A NO 964348 L NO964348 L NO 964348L
Authority
NO
Norway
Prior art keywords
gastrin
cck
benzodiazepines
modulating
heterocyclic
Prior art date
Application number
NO964348A
Other languages
English (en)
Norwegian (no)
Other versions
NO964348D0 (no
Inventor
Christopher Joseph Aquino
Elisabeth Ellen Sugg
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9407433A external-priority patent/GB9407433D0/en
Priority claimed from GB9420783A external-priority patent/GB9420783D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of NO964348D0 publication Critical patent/NO964348D0/no
Publication of NO964348L publication Critical patent/NO964348L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO964348A 1994-04-14 1996-10-11 CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner NO964348L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9407433A GB9407433D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivatives
GB9420783A GB9420783D0 (en) 1994-10-14 1994-10-14 Heterocyclic derivatives
PCT/US1995/004163 WO1995028419A1 (en) 1994-04-14 1995-04-12 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines

Publications (2)

Publication Number Publication Date
NO964348D0 NO964348D0 (no) 1996-10-11
NO964348L true NO964348L (no) 1996-12-02

Family

ID=26304703

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964348A NO964348L (no) 1994-04-14 1996-10-11 CCK- eller gastrin-modulerende 5-hetrocykliske-1,5-benzodiazepiner

Country Status (25)

Country Link
EP (1) EP0756602B1 (sk)
JP (1) JPH09511223A (sk)
KR (1) KR970702274A (sk)
CN (1) CN1176646A (sk)
AT (1) ATE181737T1 (sk)
AU (1) AU697349B2 (sk)
BR (1) BR9507381A (sk)
CA (1) CA2186900A1 (sk)
CZ (1) CZ286764B6 (sk)
DE (1) DE69510545T2 (sk)
DK (1) DK0756602T3 (sk)
ES (1) ES2135722T3 (sk)
FI (1) FI964045A (sk)
GR (1) GR3031335T3 (sk)
HU (1) HUT76135A (sk)
IL (1) IL113365A (sk)
IS (1) IS4367A (sk)
MX (1) MX9604765A (sk)
NO (1) NO964348L (sk)
NZ (1) NZ283929A (sk)
PL (1) PL180026B1 (sk)
RU (1) RU2152939C1 (sk)
SK (1) SK281433B6 (sk)
TW (1) TW369529B (sk)
WO (1) WO1995028419A1 (sk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
US6239131B1 (en) * 1996-12-10 2001-05-29 Zeria Pharmaceutical Co., Ltd. 1,5 Benzodiazepine derivatives
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
EP1123928A4 (en) * 1998-10-20 2005-02-16 Takeda Pharmaceutical 1,5-BENZODIAZEPINE COMPOUNDS, PROCESS FOR PRODUCING THE SAME, AND MEDICAMENT
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
EP1531817B1 (en) * 2002-08-27 2008-07-30 MERCK PATENT GmbH Glycinamide derivatives as raf-kinase inhibitors
EP1753766A1 (en) 2004-05-25 2007-02-21 Pfizer Products Inc. Tetraazabenzo(e)azulene derivatives and analogs thereof
PL2803662T3 (pl) * 2012-01-13 2017-09-29 Nippon Chemiphar Co., Ltd. Antagonista receptora p2x4
JP6974331B2 (ja) 2016-02-05 2021-12-01 デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. 化合物、組成物及び方法
HUE058802T2 (hu) 2016-12-09 2022-09-28 Denali Therapeutics Inc RIPK1 inhibitorokként alkalmas vegyületek
AU2020363377A1 (en) 2019-10-07 2022-04-21 Kallyope, Inc. GPR119 agonists
AU2023206890A1 (en) 2022-01-12 2024-08-22 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
BR9507381A (pt) 1997-09-23
DK0756602T3 (da) 2000-01-31
IL113365A0 (en) 1995-07-31
FI964045A0 (fi) 1996-10-09
RU2152939C1 (ru) 2000-07-20
ATE181737T1 (de) 1999-07-15
AU697349B2 (en) 1998-10-01
EP0756602A1 (en) 1997-02-05
DE69510545T2 (de) 2000-01-13
HU9602835D0 (en) 1996-12-30
NZ283929A (en) 1998-02-26
PL316870A1 (en) 1997-02-17
SK130096A3 (en) 1997-08-06
IL113365A (en) 1999-11-30
WO1995028419A1 (en) 1995-10-26
NO964348D0 (no) 1996-10-11
CZ286764B6 (en) 2000-06-14
CZ297296A3 (en) 1997-09-17
AU2239095A (en) 1995-11-10
FI964045A (fi) 1996-10-09
KR970702274A (ko) 1997-05-13
MX9604765A (es) 1998-05-31
PL180026B1 (pl) 2000-12-29
CA2186900A1 (en) 1995-10-26
TW369529B (en) 1999-09-11
CN1176646A (zh) 1998-03-18
GR3031335T3 (en) 1999-12-31
IS4367A (is) 1996-09-30
DE69510545D1 (de) 1999-08-05
ES2135722T3 (es) 1999-11-01
HUT76135A (en) 1997-06-30
SK281433B6 (sk) 2001-03-12
JPH09511223A (ja) 1997-11-11
EP0756602B1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
GB9514473D0 (en) Chemical compounds
NO904802D0 (no) Fremgangsmaate for fremstilling av aromatiske aminforbindelser.
NO904595D0 (no) Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoid.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
IT1285770B1 (it) Composti corticoidei
AR004498A1 (es) Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacion
NO904075L (no) Fremgangsmaate for oksydativ kobling av metan.
DK0756602T3 (da) CCK- eller gastrin-modulerende 5-heterocyclo-1,5-benzodiazepiner
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
DE59810106D1 (de) Substituierte 2,4-diamino-1,3,5-triazine
NO913720L (no) Fremgangsmaate for fremstilling av 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-prolin.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
RU2076517C1 (ru) Пищевой краситель
ECSP972052A (es) Quinoxalinadionas
EE9400233A (et) 1,5,6,7-tetrahüdro-4H-indasool-4-ooni sisaldav ravim, uus 1,5,6,7-tetrahüdro-4H-indasool-4-oon ja meetodid nende saamiseks
AR005835A1 (es) Derivados aromaticos sustituidos del acido fosfonico.
FI891771A0 (fi) Anordning foer uppsaettande av plogningsstakar.
FI904885A0 (fi) Registreringsanordning foer idrottsprestationer, speciellt foer haendelsefoerloppet i lagspel.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application